Purpose: To investigate the anti-tumor effect of 
INTRODUCTION
Lung cancer is a major cause of cancerassociated mortality worldwide. Among various subtypes, non-small cell lung cancer (NSCLC) is one of the most common which accounts for 80 % of all diagnosed lung cancer cases [1, 2] . Compared to small cell lung cancer (SCLC), patients with NSCLC are less sensitive to radiochemotherapy, have higher recurrence rate, and thus lower long-term survival rate [3] . Excessive proliferation and metastasis of cancer cells are major reasons for poor prognosis of NSCLC patients [4] . Therefore, identifying related genes and possible underlying mechanisms is of great importance in improving early diagnosis of NSCLC and targeted therapy development.
microRNA, a short non-coding RNA with length between 18 and 25 amino acids, is generally assumed to play a negative role in gene regulation in eukaryotic cells. Bounded to the 3'-untranslated region (UTR), microRNA can inhibit target gene transcription, even leading to the degradation of targeted mRNA. Tumor development is often accompanied with abnormal microRNA expression and distribution. Thus, microRNA is not only a possible biomarker for early diagnosis, but also a target for future targeted therapy with great potential [5] . Relatively low expression of in cancers such as hepatocellular carcinoma, pancreatic cancer, melanoma and ovarian cancer have been widely reported previously. Abnormal miR-194 expression might be related to tumor progression, and thus suggesting poor prognosis [6, 7] . Zhang et al reported that overexpression of miR-194 can inhibit migration and invasion in glioma cells [8] . Moreover, the proliferation of melanoma cells was suppressed by miR-194 overexpression [9] . However, the specific role of miR-194 in NSCLC and further underlying mechanisms have yet not been unveiled. Profilin, with a molecular weight between 12 and 15 kDa, is a family of actin-binding protein constitutively expressed in eukaryotic cells, including profilin 1, 2, 3 and 4. These proteins are involved in cell proliferation, differentiation, and cell signal transduction by regulating polymerization and depolymerization of actin [10, 11] . Profilin family, especially profilin 2, has been thoroughly studied in the field of tumorigenesis and development, however, with inconsistent results. Kim et al reported that profilin 2 promotes migration and invasion of human colorectal cancer cell line HT29 [10] , while suppressing cell proliferation in oral squamous cell carcinoma [12] . Moreover, preliminary work shown done that profilin 2 is relatively overexpressed in NSCLC 95D cells and is possibly related to epithelial-mesenchymal transition (EMT) [13] .
Therefore, the present study was to investigate the anti-tumor effect of miR-194 and possible relationship with profilin 2 in NSCLC.
EXPERIMENTAL

Bioinformatic analysis
The potential target gene of miR-194 was predicted using miRanda/mirSVR tool. In order to obtain the microRNA expression profile changes and miR-194 level changes of patients with NSCLC, we retrieved a high-throughput sequencing data from patients with lung squamous cell carcinoma (SCLC) in The Cancer Genome Atlas (TCGA) database. Selected dataset include 45 cases of healthy control tissues and 332 tumor tissues. In the Gene Expression Omnibus (GEO) database, we retrieved a microRNA microarray data about lung adenocarcinoma (accession ID: GSE51853) and different expression gene analysis was conducted for getting the microRNA expression profile. These dataset include 126 normal tissues and 76 tumor tissues. Moreover, for estimating the expression change of profilin in patients with NSCLC, two relevant cohort study data (Landi Cohort and Talbot Cohort) were collected from Oncomine database.
Cell culture
Human NSCLC cell lines (SK-MES-1, H1299, A549, HCC827 and H460) and human normal lung cell line (MRC-5) were purchased from the Cell Bank of the Chinese Academy of Science (Shanghai, China). MRC-5 and A549 cells were cultured in DMEM, while SK-MES-1, H1299, H460 and HCC827 cells were culture in RPMI-1640 medium (with 10 % fetal bovine serum), supplemented with 100 U/mL penicillin and 100 μg/mL streptomycin (all from Gibco, Carlsbad, CA, USA). Cells were cultured in a humidified environment with 5 % CO 2 at 37 °C.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted using TRIzol (Gibco) from A549 cells. miR-194 was reversed transcript using miScript II RT kit (Qiagen, Dusseldorf, Germany) and SNORD-48 was set as internal reference. For profilin 2 mRNA, SuperScript Master kit (Thermo Fisher Scientific) were used with GAPDH as internal reference. The fold change of targeted genes expressions were determined by 2 -ΔΔCt method.
Western blotting
Western blot was conducted as previously described [14] using primary antibodies specific for profilin 2 and GAPDH (Sigma-Aldrich, St. Louis, MO, USA). Image J (US NIH, Bethesda, MD, USA) was used to analyze the optical density of each protein band.
Cell transfection
Cell transfection was performed using Lipofectamine RNAiMAX kit (Thermo Fisher Scientific, Waltham, MA, USA) for miR-194 mimic and siRNA, and Lipofectamine 2000 kit (Thermo Fisher Scientific) for pcDNA3.1-PFN2 plasmid, respectively. All the procedures were performed strictly according to the manufacturer's instruction.
Dual luciferase reporter assay
The 3'-UTR sequence of profilin 2 mRNA containing wild-type or mutant miR-194 binding sites was synthesized and cloned into the PsiCHECK2 fluorescent reporter plasmid (Promega, Madison, WI, USA), respectively. Transfected cells (1×10 4 cells/well) were seeded in 96-well plates for 48 h. Relative luciferase activity was determined by Dual-Luciferase Reporter Assay System (Promega).
Cell viability assay
Transfected A549 cells (3 × 10 3 cells/well) seeded in 96-well plates were further cultured for 24, 48 and 72 h, respectively. Cell viability was determined using CCK-8 kit (Jiancheng, Nanjing, China) according to the manufacturer's instruction. The absorbance at 450 nm was determined with Multiskan (Thermo Fisher Scientific).
Scratch assay
A549 cells (4 × 10
5 cells/well) were seeded in a 6-well plate to form a monolayer. The scratch assay was performed using a p200 pipet tip [15] . Photos were taken 72 h after the first scratch, and the area of uncover zone were recorded.
Transwell assay
A549 cells (1 × 10 5 cells/well) were inoculated into the upper chamber of Matrigel-coated Transwell (8 μm pore size). After 16 h incubation, migrated cells on were fixed with 4 % formalin, and further stained with Giemsa and counted under the microscope.
Statistical analysis
All data are presented as mean ± SD (n = 3). Statistical analysis using Student's t test, MannWhitney U test or one-way ANOVA followed by Dunnett's test was performed. P-value was calculated using Prism software (GraphPad, La Jolla, CA, USA), and values < 0.05 were considered statistically significant.
RESULTS
Bioinformatic data on miR-194 and profilin expressions in patients with NSCLC
According to the dataset retrieved from TCGA, the median level of miR-194 was lower in SCLC tissues compared with matched normal tissues (Figure 1 , fold change=0.8, p < 0.05). The microarray data from GEO also showed that miR-194 level decreased in lung adenocarcinoma tissues compared with normal tissue (Figure 1 , p < 0.05). The data from Oncomine database demonstrated higher profilin 2 level both in SCLC tissues and lung adenocarcinoma tissues (Figure 2 ). These results indicated that miR-194 and profilin may play a role in the development of NSCLC. 
Effect of miR-194/profilin 2 axis on A549 cell proliferation, migration and invasion
The CCK-8 cell viability assay showed that the relative proliferation rate of A549 cells overexpressed with miR-194 was lower than that of negative control (Figure 7 , p < 0.05). The in vitro scratch assay revealed that, the migration of cells was slower after miR-194 overexpression, and the gap length at 72 h was larger than that of the negative control group (Figure 8 , p < 0.05). Transwell assay showed that the number of migrated cells was decreased after miR-194 overexpression, compared with the negative control group (Figure 9 , p < 0.05). Similar to the effect of miR-194 overexpression, cell proliferation was inhibited and the migration and invasion abilities also decreased after silencing profilin 2 using siRNA. However, the transfection of miR-194 mimic into pcDNA3.1-PFN2-transfected A549 cells partially restored the proliferation, migration and invasion ability, compared with the cells overexpressing miR-194 only, which indicated that the recovery of profilin 2 levels partially abolished the tumor suppressor effect of miR-194. The above results suggest that miR-194 may play a suppressor effect on NSCLC cells through targeted inhibition of profilin 2. 
DISCUSSION
In our present study, results from bioinformatic analysis showed that there were abnormal expressions of miR-194 and profilin 2 in normal and cancerous lung tissues, with relatively low miR-194 expression and high profilin 2 expression in NSCLC patients. The results were further confirmed by in vitro PCR assay using different NSCLC cell lines, compared to normal human lung cells, which suggest possible relationship between these two molecules. Further dual luciferase reporter assay showed that profilin 2 is the direct target of miR-194 in A549 cells. Overexpression of miR-194 could suppress profilin 2 expression both at mRNA and protein level, and further inhibit proliferation, migration and invasion of A549 cells. Similar results were found in profilin 2-knockdown A549 cells using siRNA interference. Of note, the suppressive effect was partially reversed by overexpression of profilin 2.
Previous studies related to miR-194 mainly focused on its suppressive effect on cell migration and invasion via EMT-related genes and signaling pathways. Meng et al reported that miR-194 is relatively lowly expressed in mesenchymal-like hepatic epithelial cell [7] . Overexpression of miR-194 can down-regulated mesenchymal cell marker expression, indicating the EMT process was inhibited. The metastasis of liver cancer cells was also suppressed in an animal model [7] . Similar expression pattern of miR-194 was also found in gastric cancer cells. miR-194 transfection could reverse the EMT progression, and thus inhibit migration and invasion of gastric cancer cell [16] . BMI-1, an important EMT inducer, is also a potential target of miR-194 in endometrial cancer cells [17] . Moreover, Kong et al reported that miR-194 could inhibit NudC nuclear distribution protein (hNUDC) expression, and thus suppresses migration and invasion of both PC-3 and DU-145 human prostate cancer cell lines [18] . Besides, miR-194 also exerted its anti-proliferative effect on osteosarcoma cells via CDH2 and IGF1R [19] . Furthermore, miR-194 exhibited proapoptotic effect on melanoma cells by modulating PI3K/AKT/FoxO3a and p53/p21 signaling pathway [9] .
Currently, there are few studies on the role and underlying mechanism of miR-194 in NSCLC. Zhou et al found that there is relatively low expression of miR-194 in NSCLC patients [20] . After the restoration of miR-194 level in vitro, the proliferation of tumor cells was inhibited, suggesting that the anti-tumor effect of miR-194 may be through the inhibition of its target gene hNUDC [20] . However, due to small sample size, multiple downstream targets and complex regulation network of microRNAs, more studies were warranted to validate the possible target genes of miR-194 and reveal its role in the development of NSCLC.
In the present study, by using bioinformatic analysis, we analyzed large data from TCGA database. The results suggest that there is low expression of miR-194 in NSCLC patients, which is consistent with the previous results. Moreover, the bioinformatics results were confirmed by in vitro assays. After transfection with the miR-194 mimic sequence, we found that the proliferation, migration and invasion of A549 cells were inhibited, suggesting the tumor suppressor function of miR-194 in NSCLC.
In order to further reveal the mechanism of action of miR-194, we analyzed the potential target gene profilin 2 in NSCLC. Bioinformatic analysis of two related cohort findings found that patients with NSCLC had high expression of profilin 2. In vitro analysis of NSCLC cell lines revealed that not only the profilin 2 level in the NSCLC cell lines was higher than in the normal lung cancer cell line, but the profilin 2 in the NSCLC cell line with lower miR-194 was rather higher. Further dual luciferase reporter assays, qRT-PCR and Western blot assays also validated profilin 2 as the possible target of miR-194.
At present, there are only few studies on the specific role of profilin 2 in NSCLC, while research have found that profilin 2 can promote cell migration and invasion in other types of cancer. Kim et al. found that reducing the expression of profilin 2 in colorectal cancer stem cells HT29 can not only inhibit the EMT process, but also inhibit cell migration and invasion [10] . Cui et al found that profilin 2 levels correlate with the clinicopathological features of esophageal cancer, with a poorer prognosis for patients with higher profilin 2 levels [21] . Downregulation of profilin 2 in vitro can inhibit esophageal cancer cell proliferation, migration and invasion, accompanied by changes in EMT markers, with significant decrease of mesenchymal markers [21] . These biological effects of profilin 2 may be achieved through the regulation of some signaling pathways, such as PI3K/AKT and TGF-β/Smad [22] . This present study found that cell proliferation, migration and invasion of A549 were inhibited after the silencing of profilin 2. Overexpression of profilin 2 can eliminate the tumor suppressor effect of miR-194 overexpression, manifested as promoted cell proliferation, migration and invasion. Furthermore, the investigation of the effect of miR-194/profilin 2 axis on EMT of NSCLC cells is necessary in future studies.
CONCLUSION
The findings of this study suggest that dysregulated miR-194/profilin 2 axis is involved in the development of NSCLC. MiR-194 plays a tumor suppressor role in NSCLC development. It inhibits the proliferation, migration and invasion of NSCLC cells by targeting profilin 2. Interventions targeting the miR-194/profilin 2 axis may therefore serve as a clinical strategy for the prevention and treatment of NSCLC metastases.
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